Literature DB >> 29995234

[Clostridium difficile in the intensive care unit].

F Prechter1, A Stallmach2.   

Abstract

Clostridium difficile infections (CDI) are encountered in about 1-2% of patients in the intensive care unit (ICU) and pose a special challenge to those who provide care. Only little data regarding severity and management of CDI in ICU patients in Europe are available. Extrapolation of results from one patient population to another is often difficult. The comorbidities of those patients often limit the application of general recommendations concerning diagnosis and therapy. In addition, there are a relevant percentage of patients (10-20%) with asymptomatic C. difficile colonization. The relevance for the patient and for the risk of patient to patient infection is not yet fully understood. Based on available data, we give an overview of current challenges in the diagnosis, assessment of disease course, primary management options, and alternatives in special cases and treatment failures of CDI. We also discuss prevention of new CDI in the intensive care unit.

Entities:  

Keywords:  Antibiotic stewardship; Clostridium difficile; Clostridium infection; Infections in intensive care units; Pseudomembranous colitis

Year:  2018        PMID: 29995234     DOI: 10.1007/s00063-018-0459-1

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  42 in total

1.  [S2k-guideline gastrointestinal infectious diseases and Whipple's disease].

Authors:  S Hagel; H-J Epple; G E Feurle; W V Kern; P Lynen Jansen; P Malfertheiner; T Marth; E Meyer; M Mielke; V Moos; L von Müller; J Nattermann; M Nothacker; C Pox; E Reisinger; B Salzberger; H J F Salzer; M Weber; T Weinke; S Suerbaum; A W Lohse; A Stallmach
Journal:  Z Gastroenterol       Date:  2015-05-12       Impact factor: 2.000

2.  Is Clostridium difficile infection an increasingly common severe disease in adult intensive care units? A 10-year experience.

Authors:  E Bouza; M Rodríguez-Créixems; L Alcalá; M Marín; V De Egea; F Braojos; P Muñoz; E Reigadas
Journal:  J Crit Care       Date:  2015-02-28       Impact factor: 3.425

3.  Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.

Authors:  Stuart Johnson; Thomas J Louie; Dale N Gerding; Oliver A Cornely; Scott Chasan-Taber; David Fitts; Steven P Gelone; Colin Broom; David M Davidson
Journal:  Clin Infect Dis       Date:  2014-05-05       Impact factor: 9.079

4.  Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study.

Authors:  B Gergely Szabo; B Kadar; K Szidonia Lenart; B Dezsenyi; P Kunovszki; K Fried; K Kamotsay; R Nikolova; G Prinz
Journal:  Clin Microbiol Infect       Date:  2016-09-04       Impact factor: 8.067

5.  Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection.

Authors:  Vanessa W Stevens; Richard E Nelson; Elyse M Schwab-Daugherty; Karim Khader; Makoto M Jones; Kevin A Brown; Tom Greene; Lindsay D Croft; Melinda Neuhauser; Peter Glassman; Matthew Bidwell Goetz; Matthew H Samore; Michael A Rubin
Journal:  JAMA Intern Med       Date:  2017-04-01       Impact factor: 21.873

6.  Effects of a predictive preventive model for prevention of Clostridium difficile infection in patients in intensive care units.

Authors:  Alba Cruz-Betancourt; Christopher D Cooper; Kathleen Sposato; Hermanda Milton; Patricia Louzon; Julie Pepe; Ramy Girgis; Seema V Patel; Dina Ibrahim; Sandra Van Horn; Vincent Hsu
Journal:  Am J Infect Control       Date:  2016-01-05       Impact factor: 2.918

7.  Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections.

Authors:  Alex Carignan; Sébastien Poulin; Philippe Martin; Annie-Claude Labbé; Louis Valiquette; Hamed Al-Bachari; Louis-Philippe Montpetit; Jacques Pépin
Journal:  Am J Gastroenterol       Date:  2016-09-13       Impact factor: 10.864

8.  Acquisition of Clostridium difficile on Hands of Healthcare Personnel Caring for Patients with Resolved C. difficile Infection.

Authors:  Subarna K Shrestha; Venkata C K Sunkesula; Sirisha Kundrapu; Myreen E Tomas; Michelle M Nerandzic; Curtis J Donskey
Journal:  Infect Control Hosp Epidemiol       Date:  2016-01-22       Impact factor: 3.254

9.  A two-step approach improves the diagnosis of Clostridium difficile infection.

Authors:  Melina Kachrimanidou; Zoi Tegou; Maria Chasampalioti; Kostoula Arvaniti; Efthymia Protonotariou; Lemonia Skoura
Journal:  J Microbiol Methods       Date:  2017-09-29       Impact factor: 2.363

10.  Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

Authors:  Christopher R Polage; Clare E Gyorke; Michael A Kennedy; Jhansi L Leslie; David L Chin; Susan Wang; Hien H Nguyen; Bin Huang; Yi-Wei Tang; Lenora W Lee; Kyoungmi Kim; Sandra Taylor; Patrick S Romano; Edward A Panacek; Parker B Goodell; Jay V Solnick; Stuart H Cohen
Journal:  JAMA Intern Med       Date:  2015-11       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.